98 results
Page 3 of 5
S-8
EX-99.3
1bsird3wxpekq
26 Oct 21
Registration of securities for employees
4:07pm
6-K
EX-99.1
ejo3nve3okmgeb7ux xg
6 Oct 21
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
6:00am
6-K
EX-99.2
9yco0eyq
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
rid 7qhk6cmq6fwd
14 Jul 21
Current report (foreign)
5:27pm
6-K
EX-99.1
cmxb9mniibzyjz
14 Jul 21
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
5:13pm
6-K
EX-99.1
jfj0uo
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
EX-99.1
dmjt7tm p24
4 Jun 21
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
6:05am
6-K
EX-99.2
cibbyuj
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.4
3pwur5rud7b7j
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
gd2i235eewkvgrugkclb
9 Apr 21
Extension of lock-up period in Gilead-Galapagos collaboration agreement
6:00am
6-K
EX-99.1
oq1skej
21 Jan 21
Current report (foreign)
7:49am
6-K
EX-99.1
mc8p103bds1035v
5 Jan 21
Selvita completes acquisition of Fidelta from Galapagos
7:00am
6-K
EX-99.1
3a7uku
15 Dec 20
Current report (foreign)
4:55pm
6-K
EX-99.1
e5hx77zc
24 Nov 20
Selvita to acquire Fidelta from Galapagos
7:05am
S-8
EX-4.1
46i96o5 gz3imp6
9 Oct 20
Registration of securities for employees
4:32pm
S-8
EX-99.1
mavsq5cuwcuu 1h3ws
9 Oct 20
Registration of securities for employees
4:32pm